EcoDrugPlus

Ribosomal Protein L22

Ensembl ID : ENSPEMG00000011397
Gene Symbol: RPL22
3 Cross references
21 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSPEMG00000007476
Gene Symbol: RPL23
3 Cross references
207 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSPEMG00000024234
Gene Symbol: RPL23A
2 Cross references
56 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSPEMG00000012043
Gene Symbol: RPL24
2 Cross references
223 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSPEMG00000013188
Gene Symbol: RPL26
1 Cross references
150 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSPEMG00000015793
Gene Symbol: RPL27
3 Cross references
205 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSPEMG00000011755
Gene Symbol: RPL28
3 Cross references
202 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSPEMG00000012563
Gene Symbol: RPL3
3 Cross references
278 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSPEMG00000021500
Gene Symbol: RPL35
2 Cross references
236 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSPEMG00000015291
Gene Symbol: RPL37
3 Cross references
115 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSPEMG00000008580
Gene Symbol: RPL37A
3 Cross references
33 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSPEMG00000020304
Gene Symbol: RPL38
3 Cross references
193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).